Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Ariel KlemanDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
Arun SingaviVirginia G. Piper Cancer Care Network, Scottsdale, AZ.
Lauren PommertDivision of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Angela J MathisonMellowes Center for Genomic Sciences and Precision Medicine, Milwaukee, WI.ORCID 0000-0002-6763-2710
Parameswaran HariDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0002-8800-297X
Binod DhakalDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0002-4377-9742
Meera MohanDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0002-6913-6526
Siegfried JanzDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0002-2229-5511
Jennifer M KnightDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0002-9140-3109
Mithun V ShahDivision of Hematology, Mayo Clinic Rochester Minnesota, Rochester, MN.ORCID 0000-0002-5359-336X
Carolina SchinkeMyeloma Center, Divsion of Hematology Oncology, University of Arkansas, Fayetteville, AR.ORCID 0000-0002-2699-1741
Robert BurnsNatera Oncology, Austin, TX.
George Francis SteinhardtBlood Research Institute, Versiti, Waukesha, WI.
Sridhar RaoDivision of Hematology, Department of Pediatrics, Oncology, and Transplantation, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0003-2688-9541
Karen CarlsonDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0003-0418-652X
Funding
Sequencing Coordination and Data Analysis CoreP01HL149620 · NHLBI · UNIVERSITY OF ARIZONA · PI LIANG, MINGYU · 2020 to 2024
$11.8M
Defining genetic pathways of plasma-cell neoplasiaR01CA151354 · NCI · UNIVERSITY OF IOWA · PI JANZ, SIEGFRIED · 2010 to 2022
$3.9M
Cohesin Mutations in Acute Myelogenous LeukemiaR01CA204231 · NCI · VERSITI WISCONSIN, INC. · PI RAO, SRIDHAR · 2017 to 2021
$1.9M
Bone Marrow Failure in Mice Deficient for the Extracellular Matrix Component, Laminin-gamma1K08HL127187 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI CARLSON, KAREN-SUE S · 2015 to 2019
$766k
Schwann Cell Regulation of HematopoiesisR03HL155174 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI CARLSON, KAREN-SUE S · 2021 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy. · full record | OpenQuestion